Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention

Table 3

Patient’s follow-up evaluation, according to study end-points. Time for event expressed as median (Q25–Q75).

Study end point	Positive cases; (𝑛, %)	Time for event; (months)
Death	6, 9	3 (2–34)
Readmission	12, 18	13 (5–19)
Ischemic episode	6, 9	6 (1–15)
Cardiovascular aggravation	7, 10	*
Composite end point MACE	19, 28	10 (3–16)

*Based on annual clinical follow-up for 5-years.